Atherosclerotic disease regression with statins: studies using vascular markers

Area of Science:

• Cardiovascular Medicine
• Medical Imaging
• Pharmacology

Background:

• Atherosclerosis identification and progression monitoring are crucial for managing cardiovascular disease.
• Traditional angiography has limitations in sensitivity and reproducibility for early lesion detection.
• Advanced imaging modalities are needed to accurately assess sub-clinical atherosclerosis and treatment efficacy.

Purpose of the Study:

• To review the utility of various vascular imaging techniques in assessing atherosclerosis progression.
• To evaluate the role of carotid intima media thickness (CIMT) measurement in tracking disease.
• To discuss the impact of statin therapy on atherosclerosis regression.

Main Methods:

• Comparison of angiography, intravascular ultrasound (IVUS), electron beam computed tomography (EBCT), and B-mode ultrasound for atherosclerosis assessment.
• Focus on carotid intima media thickness (CIMT) as a validated measure.
• Review of imaging studies demonstrating statin effects on plaque progression and regression.

Main Results:

• CIMT measurement is a sensitive and reproducible method for tracking atherosclerosis, outperforming angiography for early lesions.
• Intravascular ultrasound (IVUS) and electron beam computed tomography (EBCT) show promise but require further validation for progression tracking.
• Statin therapy effectively slows atherosclerosis progression and promotes regression, particularly in soft plaques, irrespective of baseline LDL-C levels.

Conclusions:

• Vascular imaging, especially CIMT, is vital for monitoring atherosclerosis and evaluating interventions.
• Statin therapy offers significant benefits in slowing and reversing atherosclerosis, supporting early treatment initiation in coronary heart disease patients.
• Continued development of imaging techniques like MRI will enhance the assessment of atherosclerosis in clinical trials.